TCRR - TCR² Therapeutics prices stock offering at $15.50 July, 29 2020 06:17 AM TCR2 Therapeutics Inc. TCR2 Therapeutics (NASDAQ:TCRR) has priced its public offering of 8M common shares at $15.50/share, for expected gross proceeds of $124M.More news on: TCR2 Therapeutics Inc., Healthcare stocks news, IPO News, , Read more ...